India's Sun Pharma gets U.S. subpoena over generic drugs pricing

MUMBAI, May 28 (Reuters) - The U.S. Department of Justice (DoJ) has subpoenaed India's largest drugmaker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday.